Johnson & Johnson to invest $55B in U.S. operations
Johnson & Johnson (NYSE: JNJ) + announced it will invest more than $55 billion in its U.S. pharma and medtech operations over the next four years. The investment is a 25% increase over its previous investment cycle. It bolsters the New Brunswick, N.J.-based company’s manufacturing, R&D and technology infrastructure. Johnson & Johnson said the investment […]









